Literature DB >> 10884292

Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI-APOE cluster.

D M Waterworth1, J A Hubacek, J Pitha, J Kovar, R Poledne, S E Humphries, P J Talmud.   

Abstract

Remnant particles of triglyceride-rich lipoproteins (RLP) are known to be a strong predictor of atherogenicity. The serum concentrations of remnant-like particle triglyceride (RLPTG) and remnant-like particle cholesterol (RLPC) have been determined in a representative sample of the Czech MONICA study (n = 285). The relationship was investigated between remnant particle triglyceride/cholesterol concentrations and polymorphisms in the genes APOC3 (-482C-->T/3238C-->G), APOE (epsilon2/epsilon3/epsilon4), APOCI (-317-321ins), APOB (signal peptide), hepatic lipase (LIPE, -480C-->T), and lipoprotein lipase (LPL, S447X). Univariate analysis showed significant effects on RLPTG associated only with the APOE genotype (P = 0.009), the APOC3 -482C-->T genotype (P = 0.018), and the APOCI -317-321ins (P = 0.014) genotype and significant effects on RLPC with APOE (P = 0.01) and APOCI -317-321ins (P = 0.021). The raising effect of the APOE genotype for both remnant cholesterol and triglyceride was confined to the epsilon2/4 (n = 6) and varepsilon4/4 (n = 3) groups, and thus when the epsilon2/4 group was omitted in order to analyze by allele (epsilon2+/epsilon3+/epsilon4+), significance was lost (P = 0.6). There was strong linkage disequilibrium between the APOE and APOCI alleles (chi(2), P < 0.001) and a multivariate ANOVA of RLPTG with all three significantly associated variants as factors demonstrated that while the APOC3 -482C-->T effect was independent of the others (P = 0.003), the APOCI -317-321ins and APOE effects were not. This was also true for the APOCI -317-321ins and APOE effects on RLPC. To assess whether APOE-CI effects on RLPC were independent of their effects on total cholesterol and triglyceride levels, multiple linear regression was used. Using multiple linear regression, it appeared that the APOE-CI effects on RLPC were independent of their effects on plasma cholesterol, but the effects of APOC3 and APOE-CI on RLPTG could not be separated from their effects on plasma Tg levels. Further characterization of this remnant particle phenotype and its genetic determinants may lead to a better understanding of its metabolism and contribution to atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884292

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke.

Authors:  Viktória Havasi; Zoltán Szolnoki; Gábor Talián; Judit Bene; Katalin Komlósi; Anita Maász; Ferenc Somogyvári; András Kondacs; Mihály Szabó; Lajos Fodor; Anita Bodor; Béla Melegh
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.

Authors:  Xiaoyun Cheng; Jun Yamauchi; Sojin Lee; Ting Zhang; Zhenwei Gong; Radhika Muzumdar; Shen Qu; H Henry Dong
Journal:  J Biol Chem       Date:  2017-01-23       Impact factor: 5.157

3.  Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.

Authors:  Javier Delgado-Lista; Francisco Perez-Jimenez; Juan Ruano; Pablo Perez-Martinez; Francisco Fuentes; Juan Criado-Garcia; Laurence D Parnell; Antonio Garcia-Rios; Jose M Ordovas; Jose Lopez-Miranda
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

4.  Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke.

Authors:  Anita Maász; Péter Kisfali; Zoltán Szolnoki; Ferenc Hadarits; Béla Melegh
Journal:  J Neurol       Date:  2008-02-18       Impact factor: 4.849

5.  Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome.

Authors:  Anita Maász; Péter Kisfali; Katalin Horvatovich; Márton Mohás; Lajos Markó; Veronika Csöngei; Bernadett Faragó; Luca Járomi; Lili Magyari; Enikô Sáfrány; Csilla Sipeky; István Wittmann; Béla Melegh
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 3.201

6.  Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice.

Authors:  Yun-Zi Liu; Xiaoyun Cheng; Ting Zhang; Sojin Lee; Jun Yamauchi; Xiangwei Xiao; George Gittes; Shen Qu; Chun-Lei Jiang; H Henry Dong
Journal:  J Biol Chem       Date:  2016-05-11       Impact factor: 5.157

7.  Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians.

Authors:  Christophe Garenc; Samuel Aubert; Jèrôme Laroche; Joël Girouard; Marie-Claude Vohl; Jean Bergeron; François Rousseau; Pierre Julien
Journal:  J Hum Genet       Date:  2004-11-12       Impact factor: 3.172

8.  Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learned.

Authors:  Anita Maasz; Bela Melegh
Journal:  Genome Med       Date:  2010-09-13       Impact factor: 11.117

9.  Severe Familial Hypertriglyceridemia: Successful Treatment With Insulin and a Modified Meal Plan.

Authors:  Ahila Ayyavoo; Palany Raghupathy; Meenal Agarwal; Paul Hofman
Journal:  J Endocr Soc       Date:  2018-11-01

Review 10.  Genetic Regulatory Networks of Apolipoproteins and Associated Medical Risks.

Authors:  Preethi Basavaraju; Rubadevi Balasubramani; Divya Sri Kathiresan; Ilakkiyapavai Devaraj; Kavipriya Babu; Vasanthakumar Alagarsamy; Vinayaga Moorthi Puthamohan
Journal:  Front Cardiovasc Med       Date:  2022-01-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.